Get the Stockscreener App
26.97
7.20%
-2.0489
Tectonic Therapeutic Inc stock is traded at $26.97, with a volume of 150.15K.
It is down -7.20% in the last 24 hours and down -7.26% over the past month.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
See More
Previous Close:
$29.02
Open:
$28.69
24h Volume:
150.15K
Relative Volume:
0.43
Market Cap:
$508.72M
Revenue:
-
Net Income/Loss:
$-74.15M
P/E Ratio:
-6.6742
EPS:
-4.0411
Net Cash Flow:
$-60.29M
1W Performance:
-3.71%
1M Performance:
-7.26%
6M Performance:
+39.40%
1Y Performance:
+41.97%
1-Day Range:
$26.31
$28.80
1-Week Range:
$26.31
$30.50
52-Week Range:
$14.38
$36.03
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Name
Tectonic Therapeutic Inc
Sector
Industry
Phone
(339) 666-3320
Address
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
26.99 | 546.98M | 0 | -74.15M | -60.29M | -4.0411 |
VRTX
Vertex Pharmaceuticals Inc
|
426.32 | 108.54B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
710.25 | 75.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
781.72 | 50.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.00 | 40.45B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
315.66 | 32.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Initiated | Stifel | Buy |
| Oct-20-25 | Initiated | Wells Fargo | Overweight |
| Sep-03-25 | Initiated | Oppenheimer | Outperform |
| Jul-21-25 | Initiated | Truist | Buy |
| Jun-11-25 | Resumed | Raymond James | Outperform |
| Apr-21-25 | Initiated | Mizuho | Outperform |
| Nov-20-24 | Initiated | Raymond James | Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | TD Cowen | Buy |
| Dec-18-23 | Downgrade | Mizuho | Buy → Neutral |
| Jan-05-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-19-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-15-21 | Initiated | BTIG Research | Buy |
| May-27-21 | Initiated | Needham | Buy |
| Mar-09-21 | Initiated | Barclays | Overweight |
| Mar-02-21 | Initiated | Stifel | Hold |
| Nov-11-20 | Initiated | Berenberg | Buy |
| Mar-31-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-19 | Initiated | Mizuho | Buy |
| Apr-05-19 | Initiated | Janney | Buy |
| Oct-10-18 | Initiated | Guggenheim | Buy |
| Oct-02-18 | Reiterated | H.C. Wainwright | Buy |
| Sep-17-18 | Initiated | H.C. Wainwright | Buy |
| Jul-16-18 | Initiated | Wedbush | Outperform |
| Jul-16-18 | Initiated | Wells Fargo | Outperform |
View All
Tectonic Therapeutic Inc Stock (TECX) Latest News
How Tectonic Therapeutic (TECX) adapts when conditions change (Slight Dip) 2026-05-06Blue Chip Stocks - Newser
MSN Money - MSN
Tectonic Therapeutic CMO sells $31,950 in stock - Investing.com
Tectonic Therapeutic (TECX) CMO sells 1,065 shares in 10b5-1 trade - Stock Titan
Tectonic Therapeutic Inc. (TECX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Stifel initiates coverage of Tectonic Therapeutic (TECX) with buy recommendation - MSN
Tectonic Therapeutic Adds Veteran Banker to Board - The Globe and Mail
Tectonic Therapeutic (TECX) details 2026 virtual meeting, board elections and say-on-pay - Stock Titan
Tectonic Therapeutic Names Jessica Chutter to Board of Directors - citybiz
Tectonic Therapeutic appoints Jessica Chutter to board of directors - marketscreener.com
Tectonic Therapeutic Appoints Jessica Chutter To Board Of Directors - TradingView
Jessica Chutter appointed to Tectonic Therapeutic board and Audit Committee - TradingView
Veteran banker Jessica Chutter joins Tectonic (NASDAQ: TECX) board - Stock Titan
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors - The Manila Times
TECX (Tectonic Therapeutic Inc.) posts narrower Q4 2025 loss than analyst estimates, but shares dip nearly one percent today.Recovery Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Tectonic Therapeutic (NASDAQ:TECX) Rating Lowered to "Strong Sell" at Wall Street Zen - MarketBeat
Tectonic Therapeutic: A $1B+ Opportunity Hinges On Upcoming Phase 2 - Seeking Alpha
Stifel Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $75 - Moomoo
Stifel Initiates Tectonic Therapeutic(TECX.US) With Buy Rating, Announces Target Price $75 - Moomoo
Entry Recap: Does Tectonic Therapeutic Inc stock have upside surprise potential2026 Momentum & AI Optimized Trade Strategies - baoquankhu1.vn
Risk Recap: Does Tectonic Therapeutic Inc stock have upside surprise potential - baoquankhu1.vn
Entry Recap: Will Tectonic Therapeutic Inc announce a stock splitOil Prices & Real-Time Market Sentiment Reports - baoquankhu1.vn
Stifel initiates Tectonic Therapeutics stock with buy rating By Investing.com - Investing.com Canada
Analysis Recap: Is Tectonic Therapeutic Inc subject to activist investor interestProfit Target & Verified High Yield Trade Plans - baoquankhu1.vn
Aug Momentum: Is Tectonic Therapeutic Inc a stock for growth or value investors2026 Institutional Moves & Daily Growth Stock Tips - baoquankhu1.vn
Risk Hedge: Is Tectonic Therapeutic Inc stock technically oversoldQuarterly Earnings Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Risk Off: Does Tectonic Therapeutic Inc stock have upside surprise potentialLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $81.50 Consensus Price Target from Analysts - Defense World
Aberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECX - MarketBeat
Is Tectonic Therapeutic (TECX) Stock Testing Support | Price at $30.25, Down 0.88%Safe Entry Stocks - Newser
Aug Action: What are analysts price targets for Tectonic Therapeutic IncEarnings Performance Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Insider Sell: Marcella Ruddy Sells Shares of Tectonic Therapeutic Inc (TECX) - GuruFocus
Tectonic Therapeutic (NASDAQ:TECX) Insider Marcella Ruddy Sells 1,000 Shares - MarketBeat
Tectonic Therapeutic (TECX) CMO sells 1,000 shares in planned trade - Stock Titan
Director at Tectonic Therapeutic (TECX) awarded 20,400 stock options at $30.78 - Stock Titan
Tectonic Therapeutic (TECX) director Nader Francois files initial Form 3 - Stock Titan
TECX Decline Deepens: Next Support in Sight - Newser
tectonic therapeutic, inc. Earnings dates - RTTNews
Tectonic Therapeutic (NASDAQ:TECX) Shares Up 9.3%What's Next? - MarketBeat
Tectonic Therapeutic Inc Stock (TECX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.78%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):